Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

INKT

MiNK Therapeutics, Inc.

CIK 0001840229 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$11.46
↑ 0.91 (8.63%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$57.09M
P/E Ratio
-4.58
EPS
-2.93
Dividend Yield
Not covered
52W Position
6%
Beta
-1.10

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-4.50
P/S
Not covered
EV/Revenue
Not covered
ROE
98.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$7.28$76.00

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$12.49M
Total Assets
$14.24M
Free Cash Flow
–

Recent news